OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Estimating the value of sodium‐glucose cotransporter‐2 inhibitors within the context of contemporary guidelines and the totality of evidence
Phil McEwan, V. Foos, Becky Martin, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 7, pp. 1830-1838
Open Access | Times Cited: 10
Phil McEwan, V. Foos, Becky Martin, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 7, pp. 1830-1838
Open Access | Times Cited: 10
Showing 10 citing articles:
SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review
Samuel Seidu, Vicki Alabraba, Sarah Davies, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 5, pp. 1099-1124
Open Access | Times Cited: 8
Samuel Seidu, Vicki Alabraba, Sarah Davies, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 5, pp. 1099-1124
Open Access | Times Cited: 8
Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data
Brendon L. Neuen, Min Jun, James Wick, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 43, pp. 100988-100988
Open Access | Times Cited: 13
Brendon L. Neuen, Min Jun, James Wick, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 43, pp. 100988-100988
Open Access | Times Cited: 13
The contemporary landscape of cardiovascular optimization in type 2 diabetes: overcoming barriers to evidence-based use of newer antihyperglycemic agents
K. Malas, Salman Kazmi, Yu Mi Kang, et al.
Expert Opinion on Pharmacotherapy (2025)
Closed Access
K. Malas, Salman Kazmi, Yu Mi Kang, et al.
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Bridging the gap in cardiovascular care in diabetic patients: are cardioprotective antihyperglycemic agents underutilized?
André Scheen
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 11, pp. 1053-1062
Closed Access | Times Cited: 8
André Scheen
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 11, pp. 1053-1062
Closed Access | Times Cited: 8
KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD
Amy K. Mottl, Susanne B. Nicholas
American Journal of Kidney Diseases (2023) Vol. 83, Iss. 3, pp. 277-287
Closed Access | Times Cited: 6
Amy K. Mottl, Susanne B. Nicholas
American Journal of Kidney Diseases (2023) Vol. 83, Iss. 3, pp. 277-287
Closed Access | Times Cited: 6
Utilization and cost of non‐insulin glucose‐lowering drugs in Australia from 2013 to 2023
Peter Shane Hamblin, Arul Earnest, Anthony Russell, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 11, pp. 4924-4932
Closed Access | Times Cited: 1
Peter Shane Hamblin, Arul Earnest, Anthony Russell, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 11, pp. 4924-4932
Closed Access | Times Cited: 1
Estimating the population-level kidney benefits of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease in Australian primary care
Brendon L. Neuen, Min Jun, James Wick, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Brendon L. Neuen, Min Jun, James Wick, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Precision medicine in Type 2 Diabetes: Targeting SGLT2-inhibitor Treatment For Kidney Protection
Thijs Jansz, Katherine Young, Rhian Hopkins, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Thijs Jansz, Katherine Young, Rhian Hopkins, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Effectiveness and mechanisms of sodium-dependent glucose transporter 2 inhibitors in type 2 diabetes and heart failure patients
Y. Zhang, Haisheng Hu, Baoqing Sun
World Journal of Cardiology (2024) Vol. 16, Iss. 10, pp. 611-615
Closed Access
Y. Zhang, Haisheng Hu, Baoqing Sun
World Journal of Cardiology (2024) Vol. 16, Iss. 10, pp. 611-615
Closed Access
Pharmacological Nephroprotection in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus—Clinical Practice Position Statement of the Polish Society of Nephrology
Marcin Adamczak, Ilona Kurnatowska, Beata Naumnik, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12941-12941
Open Access
Marcin Adamczak, Ilona Kurnatowska, Beata Naumnik, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12941-12941
Open Access
Results of the DAPA-CKD trial and their impact on clinical practice
О. V. Bilchenko
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) (2023) Vol. 19, Iss. 4, pp. 300-305
Open Access
О. V. Bilchenko
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) (2023) Vol. 19, Iss. 4, pp. 300-305
Open Access
